Pradžia › Neuroblastoma › Koloradas › Aurora

Neuroblastoma klinikiniai tyrimai Aurora, CO

8 tyrimai dėl Neuroblastoma ieško dalyvių vietose Aurora ir aplinkui (apytiksliai 30 mylių spinduliu). Atidarykite tyrimą, kad pamatytumėte, kas gali dalyvauti ir kaip susisiekti su tyrimo komanda.

Oficialus tyrimo tekstas (anglų kalba)

Ieškote dalyvių tyrimui? Pateikite jį šio puslapio viršuje – $99 už 30 dienų →

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

Renkami dalyviai3 fazė

Children's Hospital Colorado, Aurora

Iki 30 metų · Visoms lytims · Atnaujinta 2026-10-02 · NCT06172296

Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)

Renkami dalyviai1/2 fazė

Children's Hospital Colorado-Center for Cancer and Blood Disorders ( Site 1016), Aurora

6 Months – 25 Years · Visoms lytims · Atnaujinta 2026-09-17 · NCT06395103

Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

Renkami dalyviai3 fazė

Children's Hospital Colorado, Aurora

365 Days – 30 Years · Visoms lytims · Atnaujinta 2026-08-25 · NCT03126916

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

Renkami dalyviai1/2 fazė

Children's Hospital Colorado, Aurora

12 Months – 30 Years · Visoms lytims · Atnaujinta 2026-08-25 · NCT04851119

NANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) Trial

Renkami dalyviai2 fazė

Children's Hospital Colorado, Aurora

Amžius nuo 1 iki 31 · Visoms lytims · Atnaujinta 2026-07-20 · NCT06450041

Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma

Renkami dalyviai1/2 fazė

Children's Hospital Colorado, Aurora

12 Months – 30 Years · Visoms lytims · Atnaujinta 2026-05-19 · NCT04901702

Neuroblastoma Biology Study

Renkami dalyviaiStebimasis tyrimas

Children Hospital of Colorado, Aurora

31 Days – 99 Years · Visoms lytims · Atnaujinta 2026-03-23 · NCT01587300

A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors

Renkami dalyviai2 fazė

Children's Hospital of Colorado, Aurora

18 Months – 40 Years · Visoms lytims · Atnaujinta 2025-08-12 · NCT05135975

Neuroblastoma tyrimai kituose miestuose

Kiti tyrimai Aurora

Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.